Breast Cancer Research and Treatment

, Volume 102, Issue 2, pp 129–135

Significance of interleukin-6 (IL-6) in breast cancer (review)


DOI: 10.1007/s10549-006-9328-3

Cite this article as:
Knüpfer, H. & Preiß, R. Breast Cancer Res Treat (2007) 102: 129. doi:10.1007/s10549-006-9328-3


Cytokines are factors that are known to have both tumor-promoting and inhibitory effects on breast cancer growth depending presumably on their relative concentrations and the presence of other modulating factors. Different cytokines play an important role in controlling the immune system. Interleukin-6 (IL-6) is a pleiotropic cytokine with obviously tumor-promoting and tumor-inhibitory effects. Here, we review the role of IL-6 in in vitro experiments of breast tumor cells, in breast tumor tissues (BTs) and assess its potential as a prognostic indicator in breast cancer patients. A literature search was conducted using PubMed, restricted to articles published in English language. In summary, results regarding the effect of IL-6 on breast tumor cells and on BTs are not unique indicating both tumor-promoting and inhibitory effects of IL-6. Concerning patients’ serum IL-6 levels, data are surprisingly unique showing IL-6 to be a negative prognosticator in breast tumor patients.


Breast cancer Interleukin-6 Prognostic factor 
Download to read the full article text

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  1. 1.Institute of Clinical PharmacologyUniversity of LeipzigLeipzigGermany

Personalised recommendations